K-pop

Mashiro, a member of the girl group Maydin, to Release Solo Debut Album Next Month

Former member of Kepler, the debut group from 'Girls Planet' Maidin Unveils Stage for the First Time at Concert in Japan

KIM HYUNSIK
2026-07-22 09:02:53
[Edaily Starin Reporter KIM HYUNSIK ] Mashirow, a member of the girl group MADEIN, is launching her solo singing career.
Mashiro (
Photo
courtesy of
143 Entertainment
)
Timetable (Photo courtesy of 143 Entertainment)
According to her agency, 143 Entertainment, on the 22nd, Mashiro will release her solo debut mini-album, “24/11,” on various online music platforms on the 19th of next month.
Mashiro, who is from Japan, joined the debut group Kep1er through Mnet’s “Girls Planet 999: Girl Group Battle” and has been active as a member of Maydin since September 2024. This marks her first solo album release.
The agency revealed Masiro’s solo album promotional schedule via its official social media channels today. According to the schedule, Masiro will sequentially unveil various content—including the tracklist, concept images, a trailer, and a music video teaser—leading up to the album’s release.
Mashiro will debut her solo song on stage for the first time at MADEIN’s inaugural concert, “MADEIN LINK UP 2026,” to be held in Kobe, Japan, on the 31st.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02